Michael Amoroso
Chief Executive Officer en PRECISION BIOSCIENCES, INC. .
Fortuna: 873 863 $ al 31/03/2024
Cargos activos de Michael Amoroso
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ABEONA THERAPEUTICS INC. | Chairman | 14/10/2021 | - |
Director/Board Member | 19/03/2021 | 14/10/2021 | |
Chief Executive Officer | 19/03/2021 | 14/10/2021 | |
Chief Operating Officer | 01/11/2020 | 19/03/2021 | |
Corporate Officer/Principal | 09/07/2020 | 01/11/2020 | |
President | 19/03/2021 | 14/10/2021 | |
PRECISION BIOSCIENCES, INC. | Director/Board Member | 15/10/2021 | - |
Chief Executive Officer | 15/10/2021 | - | |
President | 15/10/2021 | - |
Historial de carrera de Michael Amoroso
Antiguos cargos conocidos de Michael Amoroso.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
KITE PHARMA INC | Corporate Officer/Principal | 01/08/2018 | 01/01/2020 |
Formación de Michael Amoroso.
Rider University | Undergraduate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 6 |
Operativa
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
Sectorial
Health Technology | 4 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ABEONA THERAPEUTICS INC. | Health Technology |
PRECISION BIOSCIENCES, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Kite Pharma, Inc.
Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Amoroso
- Experiencia